GlassScriptPhysician profile
Coreen Kelly
NPI 1790319994
$822.52
in general payments reported to CMS, 2019-2025
14 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.73 · 2022: $34.45 · 2023: $65.37 · 2024: $193 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $310.47 | 2025 | Senza |
| Nevro Corp. | $158.21 | 2024 | Senza |
| Protega Pharmaceutials INC | $84.64 | 2025 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.69 | 2025 | Relistor |
| Abbvie INC. | $40.28 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $24.81 | 2023 | Xtampza |
| Amgen INC. | $22.71 | 2022 | |
| Medtronic, INC. | $22.24 | 2025 | Corevalve Evolut R |
| Averitas Pharma INC. | $21.89 | 2023 | Qutenza |
| Nalu Medical, INC. | $20.91 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $18.91 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $18.67 | 2023 | Ztlido |
| Valinor Pharma, LLC | $15.90 | 2024 | Movantik |
| Novo Nordisk INC | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coreen Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.